Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 06/18/24
Beasley Allen and Levin Papantonio: Leading Law Firms Seek Protection for Future Victims of Johnson & Johnson Talc ProductsBusiness Wire • 06/17/24
Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancerPRNewsWire • 06/17/24
TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myelomaPRNewsWire • 06/14/24
Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/12/24
Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson's Use of Bankruptcy StrategyBusiness Wire • 06/12/24
Johnson & Johnson to pay $700 million settlement over talc products linked to cancerFast Company • 06/12/24
With A Similar Revenue Base Is Johnson & Johnson A Better Pick Despite The 30% Fall In Tesla Stock This Year?Forbes • 06/12/24
Time to Pounce: 2 High-Yielding Dow Stocks That Are Begging to Be Bought Right NowThe Motley Fool • 06/11/24